Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Bart Barlogie Frits van Rhee Antje Hoering Elias Anaissie Sarah Waheed |
| Publication date | May 25, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |